Lipid-poor renal angiomyolipoma: Differentiation from clear cell renal cell carcinoma using wash-in and washout characteristics on contrast-enhanced computed tomography
- Authors:
- Published online on: February 9, 2016 https://doi.org/10.3892/ol.2016.4214
- Pages: 2327-2331
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Abstract
In the present study, a total of 82 patients (42 men and 40 women; age range, 24‑84 years), including 34 patients with lipid‑poor renal angiomyolipoma (AML) and 49 with clear cell renal cell carcinoma (RCC), who had undergone multiphase contrast‑enhanced computed tomography (CT) (i.e., CT with unenhanced, corticomedullary, nephrographic and 5‑min delay phase scanning) were evaluated. The peak enhancement attenuation value, net enhancement attenuation value, enhancement ratio, washout value and washout ratio were calculated to compare the enhancement characteristics between the two diseases. The results revealed that the lipid‑poor AMLs had a significantly higher mean attenuation value compared with that of CCRCCs on unenhanced CT scans (37.8 vs. 30.9 HU; Mann‑Whitney U test, P=0.003). In addition, significant differences were found between lipid‑poor AMLs and CCRCCs with regard to wash‑in (Mann‑Whitney U test, P=0.001) and enhancement ratios (Mann‑Whitney U test, P=0.010) on contrast‑enhanced CT scans. A receiver operating characteristic (ROC) analysis revealed an area under the curve (AUC) of 0.722 using wash‑in for differentiation between CCRCCs and lipid‑poor AMLs. Lipid‑poor AMLs exhibited a reduced washout of contrast enhancement (35.8±32.7 HU washout value; 29.4±0.187% washout ratio) compared with that of CCRCCs (48.3±28.4 HU washout value; 35.7±0.148% washout ratio; Mann‑Whitney U test, P=0.037 and P=0.204, respectively). The ROC analysis result yielded an AUC of 0.639 for the use of washout to differentiate CCRCCs from lipid‑poor AMLs. In summary, a larger wash‑in and washout of contrast enhancement is a predictor that a lesion is CCRCC.
